Insider Trading Alert - SPR, RTN And SGMO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 12, 2014, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $10,031,220.00.

Highlighted Stocks Traded by Insiders:

Spirit AeroSystems Holdings (SPR) - FREE Research Report

Johnson Robert D, who is Director at Spirit AeroSystems Holdings, sold 1,500 shares at $39.50 on Sept. 12, 2014. Following this transaction, the Director owned 19,358 shares meaning that the stake was reduced by 7.19% with the 1,500-share transaction.

The shares most recently traded at $39.21, down $0.29, or 0.74% since the insider transaction. Historical insider transactions for Spirit AeroSystems Holdings go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 120,787

The average volume for Spirit AeroSystems Holdings has been 1.5 million shares per day over the past 30 days. Spirit AeroSystems Holdings has a market cap of $5.2 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 15.35% year-to-date as of the close of trading on Friday.

Spirit AeroSystems Holdings, Inc., through its subsidiaries, operates as a non-original equipment manufacturer (OEM) that designs and manufactures commercial aerostructures worldwide. It operates in three segments: Fuselage Systems, Propulsion Systems, and Wing Systems. Currently, there are 9 analysts who rate Spirit AeroSystems Holdings a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPR - FREE

TheStreet Quant Ratings rates Spirit AeroSystems Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Spirit AeroSystems Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Raytheon (RTN) - FREE Research Report

Swanson William H, who is Chairman of the Board at Raytheon, sold 100,000 shares at $100.31 on Sept. 12, 2014. Following this transaction, the Chairman of the Board owned 547,310 shares meaning that the stake was reduced by 15.45% with the 100,000-share transaction.

Yuse Richard R, who is Vice President at Raytheon, sold 7,529 shares at $100.00 on Sept. 12, 2014. Following this transaction, the Vice President owned 65,439 shares meaning that the stake was reduced by 10.32% with the 7,529-share transaction.

The shares most recently traded at $100.71, up $0.71, or 0.7% since the insider transaction. Historical insider transactions for Raytheon go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 113,339

The average volume for Raytheon has been 1.5 million shares per day over the past 30 days. Raytheon has a market cap of $31.4 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 11.1% year-to-date as of the close of trading on Friday.

Raytheon Company develops integrated products, services, and solutions in the areas of sensing; effects; command, control, communications, and intelligence; mission support; and cyber and information security worldwide. The stock currently has a dividend yield of 2.4%. The company has a P/E ratio of 15.7. Currently, there are 7 analysts who rate Raytheon a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RTN - FREE

TheStreet Quant Ratings rates Raytheon as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Raytheon Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sangamo BioSciences (SGMO) - FREE Research Report

Wolff Henry Ward, who is Exec VP & CFO at Sangamo BioSciences, sold 2,000 shares at $12.31 on Sept. 12, 2014. Following this transaction, the Exec VP & CFO owned 216,347 shares meaning that the stake was reduced by 0.92% with the 2,000-share transaction.

The shares most recently traded at $12.23, down $0.08, or 0.65% since the insider transaction. Historical insider transactions for Sangamo BioSciences go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 6,798
  • 24-Week # shares sold: 12,798

The average volume for Sangamo BioSciences has been 772,900 shares per day over the past 30 days. Sangamo BioSciences has a market cap of $873.2 million and is part of the health care sector and drugs industry. Shares are down 9.43% year-to-date as of the close of trading on Friday.

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Currently, there are 3 analysts who rate Sangamo BioSciences a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SGMO - FREE

TheStreet Quant Ratings rates Sangamo BioSciences as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and weak operating cash flow. Get the full Sangamo BioSciences Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Stocks Rise Sharply, Facebook Ignites a Nasdaq Rally

Stocks Rise Sharply, Facebook Ignites a Nasdaq Rally

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company

Jim Cramer: Chipotle Shares Are Probably Done Going Down

Jim Cramer: Chipotle Shares Are Probably Done Going Down

Jim Cramer: This Is a Sad Time for Southwest Airlines

Jim Cramer: This Is a Sad Time for Southwest Airlines

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations